179 related articles for article (PubMed ID: 35737372)
1. Molecular Mechanism of Protein Arginine Deiminase 2: A Study Involving Multiple Microsecond Long Molecular Dynamics Simulations.
Cicek E; Monard G; Sungur FA
Biochemistry; 2022 Jul; 61(13):1286-1297. PubMed ID: 35737372
[TBL] [Abstract][Full Text] [Related]
2. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
3. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
4. Epitope-Based Chicken-Derived Novel Anti-PAD2 Monoclonal Antibodies Inhibit Citrullination.
Aosasa M; Hossain MS; Sakata T; Koga K; Shigemitsu T; Shoya Y; Yamaguchi M; Saito K; Kim M
J Immunol Res; 2021; 2021():6659960. PubMed ID: 33937418
[TBL] [Abstract][Full Text] [Related]
5. PAD2: A potential target for tumor therapy.
Teng Y; Chen Y; Tang X; Wang S; Yin K
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188931. PubMed ID: 37315720
[TBL] [Abstract][Full Text] [Related]
6. Potential role for PAD2 in gene regulation in breast cancer cells.
Cherrington BD; Zhang X; McElwee JL; Morency E; Anguish LJ; Coonrod SA
PLoS One; 2012; 7(7):e41242. PubMed ID: 22911765
[TBL] [Abstract][Full Text] [Related]
7. PAD2-Mediated Citrullination Contributes to Efficient Oligodendrocyte Differentiation and Myelination.
Falcão AM; Meijer M; Scaglione A; Rinwa P; Agirre E; Liang J; Larsen SC; Heskol A; Frawley R; Klingener M; Varas-Godoy M; Raposo AASF; Ernfors P; Castro DS; Nielsen ML; Casaccia P; Castelo-Branco G
Cell Rep; 2019 Apr; 27(4):1090-1102.e10. PubMed ID: 31018126
[TBL] [Abstract][Full Text] [Related]
8. Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2.
Zheng L; Nagar M; Maurais AJ; Slade DJ; Parelkar SS; Coonrod SA; Weerapana E; Thompson PR
Biochemistry; 2019 Jul; 58(27):3042-3056. PubMed ID: 31243954
[TBL] [Abstract][Full Text] [Related]
9. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism.
Dreyton CJ; Knuckley B; Jones JE; Lewallen DM; Thompson PR
Biochemistry; 2014 Jul; 53(27):4426-33. PubMed ID: 24989433
[TBL] [Abstract][Full Text] [Related]
11. Theoretical insights into the protonation states of active site cysteine and citrullination mechanism of Porphyromonas gingivalis peptidylarginine deiminase.
Zhao C; Ling B; Dong L; Liu Y
Proteins; 2017 Aug; 85(8):1518-1528. PubMed ID: 28486790
[TBL] [Abstract][Full Text] [Related]
12. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
13. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor α target gene activation.
Zhang X; Bolt M; Guertin MJ; Chen W; Zhang S; Cherrington BD; Slade DJ; Dreyton CJ; Subramanian V; Bicker KL; Thompson PR; Mancini MA; Lis JT; Coonrod SA
Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13331-6. PubMed ID: 22853951
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells.
Li F; Miao L; Xue T; Qin H; Mondal S; Thompson PR; Coonrod SA; Liu X; Zhang X
J Exp Clin Cancer Res; 2019 Oct; 38(1):414. PubMed ID: 31601253
[TBL] [Abstract][Full Text] [Related]
15. Peptidylarginine deiminase 2 suppresses inhibitory {kappa}B kinase activity in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Lee HJ; Joo M; Abdolrasulnia R; Young DG; Choi I; Ware LB; Blackwell TS; Christman BW
J Biol Chem; 2010 Dec; 285(51):39655-62. PubMed ID: 20937835
[TBL] [Abstract][Full Text] [Related]
16. Peptidylarginine Deiminase 2 Knockout Improves Survival in hemorrhagic shock.
Zhou J; Biesterveld BE; Li Y; Wu Z; Tian Y; Williams AM; Tian S; Gao W; Bhatti UF; Duan X; Wang T; Zhang J; Jiang B; Wang Z; Alam HB
Shock; 2020 Oct; 54(4):458-463. PubMed ID: 31764615
[TBL] [Abstract][Full Text] [Related]
17. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination.
Sun B; Chang HH; Salinger A; Tomita B; Bawadekar M; Holmes CL; Shelef MA; Weerapana E; Thompson PR; Ho IC
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723060
[TBL] [Abstract][Full Text] [Related]
19. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
20. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
